What is the most useful and cost-effective strategy to screen for left ventricular systolic dysfunction in clinical practice?
Yamada
Ayako
A
Yamada
Yuichiro
Y
Okada
Keiji
K
D015415:Biomarkers / Q000097:blood; D003362:Cost-Benefit Analysis; D004452:Echocardiography / Q000191:economics; D004562:Electrocardiography / Q000191:economics; D006801:Humans; D008403:Mass Screening / Q000191:economics; D020097:Natriuretic Peptide, Brain / Q000097:blood; D010446:Peptide Fragments / Q000097:blood; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis*
D015415:Biomarkers; D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain